mutations driving cll evolution progression relapse
genetic alterations drive tumorigenesis evolve course disease therapy central questions cancer biology identify recurrently mutated genes recurrent somatic copy number variations whole-exome sequencing chronic lymphocytic leukaemia cll matched germline dna samples collected prospective clinical trial include previously unrecognized putative cancer drivers rps15 ikzf3 collectively identify rna processing export myc activity mapk signalling central pathways involved cll clonality analysis large data set enabled reconstruction temporal relationships driver events direct comparison matched pre-treatment relapse samples patients demonstrated highly frequent clonal evolution thus large sequencing data sets clinically informative samples enable discovery novel genes associated cancer network relationships driver events impact disease relapse clinical outcome
